ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1540

Association of Hypoalbuminemia with Serious Infections in Systemic Lupus Erythematosus Patients Receiving Dialysis

Ping Hsuan Kuo1, Pu Jun Fang2, Chien-Chih Lai3 and Yi-Syuan Sun4, 1Taipei Veteran General Hospital, Taipei City, Taiwan (Republic of China), 2Tri-Service General Hospital, Hukou Township, Taiwan (Republic of China), 3Taipei Veterans General Hospital, Taipei City, Taiwan (Republic of China), 4taipei VGHTPE, ???, Taiwan (Republic of China)

Meeting: ACR Convergence 2025

Keywords: Infection, Lupus nephritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1517–1552) Systemic Lupus Erythematosus – Treatment Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus nephritis, a key manifestation of systemic lupus erythematosus (SLE), can progress to end-stage kidney disease and increase patient burden. While patients with SLE on maintenance dialysis face high infection-related morbidity and mortality, the risk factors for serious infections in this population remain poorly understood. We aimed to identify risk factors for serious infections and evaluate the incidence and types of infections in patients with SLE undergoing dialysis.

Methods: A retrospective cohort of 184 patients with SLE on dialysis between 2008 and 2023 was analyzed. Serious infections were defined as infections that required hospitalization. Cox proportional hazard models identified risk factors for serious infections, while Kaplan-Meier analyses estimated cumulative risks.

Results: A total of 388 episodes of serious infections occurred in 121 patients and the incidence rate of serious infections was 20.4/100 patient-years (PYs). The median time to the first serious infection was 620 days. Intra-abdominal infections (7.4/100 PYs) and pneumonia (5.4/100 PYs) were the most common infections. Male sex (hazard ratio [HR] 1.72, 95% confidence interval [CI] CI 1.02-2.89) and albumin levels (HR 0.70, 95% CI 0.50-0.98) were independent risk factors for serious infections. Kaplan-Meier analysis confirmed that male sex and lower albumin levels were associated with risk of serious infections (log-rank P = 0.009 and 0.004, respectively). During the follow-up, a total of 18 patients died, with infection being the leading cause of mortality.

Conclusion: Serious infections are common in patients with SLE on maintenance dialysis. Male sex and hypoalbuminemia increase the risk of serious infections. Close monitoring and targeted interventions are crucial to reduce infection-related morbidity and mortality in patients with SLE on dialysis.

Supporting image 1Table 1. Characteristics of patients with SLE at the initiation of dialysis.

Supporting image 2Table 2. Risk factors analysis of the serious infections among patients with SLE on maintenance dialysis.

Supporting image 3Figure 1. Kaplan–Meier survival estimates for patients with SLE undergoing dialysis, stratified by sex. SLE, systemic lupus erythematosus


Disclosures: P. Kuo: None; P. Fang: None; C. Lai: None; Y. Sun: None.

To cite this abstract in AMA style:

Kuo P, Fang P, Lai C, Sun Y. Association of Hypoalbuminemia with Serious Infections in Systemic Lupus Erythematosus Patients Receiving Dialysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/association-of-hypoalbuminemia-with-serious-infections-in-systemic-lupus-erythematosus-patients-receiving-dialysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-hypoalbuminemia-with-serious-infections-in-systemic-lupus-erythematosus-patients-receiving-dialysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology